Insights

More Articles Back to Article

Moderna's COVID-19 vaccine under rolling review in EU

The European Medicines Agency's Committee for Medicinal Products for Human Use has initiated a rolling review for Moderna's mRNA-1273 vaccine candidate and is assessing the first set of data submitted. Moderna had said in October it would file for real-time review of its COVID-19 vaccine in Europe and announced this month that it had sufficient data for a first interim analysis of the company's Phase III COVID-19 vaccine trial. Reuters (11/16)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!